Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cognitive Effects of AR Directed Therapies for Advanced Prostate Cancer
NCT03016741Phase 4Active, not recruiting
- Sponsor
- Northwestern University
- Start
- Mar 2017
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Abiraterone Acetate Tablets (I), enzalutamide in prostate cancer (PCa), sponsored by Northwestern University. Started Mar 2017; status: active, not recruiting.
02
Drugs
Abiraterone Acetate Tablets (I)enzalutamide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03016741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03016741.